FilingIndex
← The Wire
BNTCNasdaq

Benitec Biopharma Inc.

Pharmaceutical Preparations · DE · CIK 1808898

Benitec Biopharma develops genetic medicines using a "silence and replace" approach to treat genetic disorders

red 8-K · 90d
$384M
Market cap
$12.70
Last close
+2.7%
1D
+3.3%
5D
98K
Volume
Price · last 39 sessions+4.3%
May 4L $10.39 · H $13.63Jun 29
154
Total filings
May 29, 2026
Last filing
06/30
Fiscal year end

Insider Activity

◆ Cluster Buy · 3 insiders

In the 90 days to Dec 29, 2025: 3 insiders bought $22.4M.

DateInsiderActionSharesPriceValue
Dec 29, 2025Cowen AaronDirector,TenPercentOwnerBuy65,800$13.44$884K
Dec 29, 2025Cowen AaronDirector,TenPercentOwnerBuy11,587$13.44$156K
Dec 26, 2025Cowen AaronDirector,TenPercentOwnerBuy14,320$13.10$188K
Dec 26, 2025Cowen AaronDirector,TenPercentOwnerBuy2,516$13.10$33K
Dec 23, 2025Cowen AaronDirector,TenPercentOwnerBuy42,600$12.85$547K
Dec 23, 2025Cowen AaronDirector,TenPercentOwnerBuy7,400$12.85$95K
Dec 22, 2025Averill Madison Master Fund, Ltd.TenPercentOwnerBuy16,650$12.08$201K
Dec 22, 2025Averill Madison Master Fund, Ltd.TenPercentOwnerBuy2,892$12.08$35K
Dec 19, 2025Averill Madison Master Fund, Ltd.TenPercentOwnerBuy13,950$11.48$160K
Dec 19, 2025Averill Madison Master Fund, Ltd.TenPercentOwnerBuy2,434$11.48$28K
Dec 18, 2025Averill Madison Master Fund, Ltd.TenPercentOwnerBuy8,700$11.24$98K
Dec 18, 2025Averill Madison Master Fund, Ltd.TenPercentOwnerBuy1,515$11.24$17K
Nov 7, 2025Suvretta Capital Management, LlcDirector,TenPercentOwnerBuy751,111$13.50$10.1M
Nov 7, 2025Suvretta Capital Management, LlcDirector,TenPercentOwnerBuy730,370$13.50$9.9M

Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.

Similar companies

Comparable business profile · signals at a glance